Artiva Biotherapeutics (ARTV) Change in Acquisitions & Divestments (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $22.0 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $22.0 million, down 24.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $103.9 million (up 49.78% YoY), and the FY2025 annual result was $110.9 million, up 96.76% from the prior year.
• Change in Acquisitions & Divestments declined to $22.0 million in Q1 2026 per ARTV's latest filing, from $24.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $29.6 million in Q3 2025 and troughed at $12.0 million in Q3 2023.
• A 4-year average of $19.5 million and a median of $16.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments surged 138.9% in 2025, then decreased 24.14% in 2026.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at $12.8 million in 2023, then climbed by 8.98% to $14.0 million in 2024, then soared by 72.04% to $24.0 million in 2025, then declined by 8.33% to $22.0 million in 2026.
• Business Quant data shows ARTV's Change in Acquisitions & Divestments at $22.0 million in Q1 2026, $24.0 million in Q4 2025, and $29.6 million in Q3 2025.